A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
The scientists driving Neion Bio’s effort to engineer chickens as scalable, lower-cost platforms for biologics manufacturing.
Dr. James Kehler Dr. James Kehler at Neion Bio’s facilities in the Ford Center Incubator at Rockefeller University. James Kehler and Sven Bocklandt Dr. James Kehler (left) and Dr. Sven Bocklandt ...
In a study published in the Journal of Materials Chemistry A, Nagoya University researchers demonstrated that native soil ...
Clues to the genetic code’s origin may be hidden in tiny protein fragments, revealing a synchronized and highly structured ...
Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...
Peripheral nerve injuries, often caused by traumatic events such as car accidents, falls or battlefield injuries, can leave patients with long-term weakness, numbness or loss of function. Despite ...
NARO had assigned Dr Kiggundu to chair a committee constituted to reposition NARO’s Laboratory Centre of Excellence at the ...
LC: Manufacturability is the field's most critical near-term challenge, especially for ex vivo cell therapies. Encouragingly, ...
Novel approach to engineering complex microbial traits generates tens of millions of gene combinations, enabling gain-of-function traits beyond those ...
Using gene-editing technology, scientists and start-ups are aiming to provide electricity-free illumination.
Moolec Science has achieved a breakthrough in its molecular farming tech, engineering pea seeds to produce bovine myoglobin, a heme-containing protein.